top of page

MetaHeps Technology
MetaHeps cells are derived from monocytes taken from individual patients with suspected DILI, carrying the genetic makeup and immunogenicity of the donor (e.g., HLA haplotype).
Blood
 sample
30-50mL of fresh blood sample or frozen PBMCs from patients
MetaHeps differentiation
Cells with donor specific characteristics
12-14 days
Toxicity assessment
Study termination and LDH analysis
1 day
Data

Analysis
Database of values across DILI, non-DILI controls, and normal healthy volunteer samples
1 day
Products & Services
We are the DILI company offering cutting edge laboratory services and advisory expertise for Drug-Induced Liver Injury (DILI) in clinical trials.
What we can do for you

Expert Advisory Services/Consulting
Our DILI team of experienced scientists with proven expertise in clinical and experimental hepatology ensures the highest quality standards. Analysis of clinical DILI signals, hypothesis generation, experimental design of new study proposals, data analyses, reporting.
Mechanistic Investigations
Drug-induced hepatocellular transporter inhibition: monolayer, vesicular and transwell transport assays: OATP1B1, OATP1B3, OATP2B1, NTCP, BSEP, MRP2, and MDR3.​
Mitochondrial Dysfunction: Glucose/Galactose ATP assay in HuH7, HepG2 and cell lines upon request. ​
bottom of page